Trials / Terminated
TerminatedNCT04141865
Effect of Xen Implantation on the Aqueous Humor Proteome
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 3 (actual)
- Sponsor
- Price Vision Group · Industry
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine how the aqueous humor proteome changes after implantation of a Xen microstent for treatment of glaucoma.
Detailed description
The purpose of this study is to determine how the aqueous humor proteome changes after implantation of a Xen microstent for treatment of glaucoma using liquid chromatography mass spectrometry.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Xen | Xen microstent implantation |
| DEVICE | Aqueous shunt | Aqueous shunt implantation |
Timeline
- Start date
- 2019-10-24
- Primary completion
- 2022-02-15
- Completion
- 2022-02-15
- First posted
- 2019-10-28
- Last updated
- 2022-03-03
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04141865. Inclusion in this directory is not an endorsement.